GN BioNex Capsule
GN BioNex Capsule : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministère de la santé de Malaisie / NPRA, Pharmaceutical Products, CC BY 4.0
- Registration number
- MAL22046055N
- Type
- Health supplement
- Published status
- PRODUCT APPROVED
- Licence holder
- GN NEUTRICEUTICALS SDN. BHD.
- Manufacturer
- GN NEUTRICEUTICALS SDN. BHD.
- Registration date
- 2022-04-08
- Published validity end
- 2027-04-08
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
No point flagged by the rules applied to recognised ingredients.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| LACTOBACILLUS ACIDOPHILUS | LACTOBACILLUS ACIDOPHILUS[40 mg,500 mg] | Not identified |
| LACTOBACILLUS RHAMNOSUS | LACTOBACILLUS RHAMNOSUS[40 mg,500 mg] | Not identified |
| BIFIDOBACTERIUM LONGUM | BIFIDOBACTERIUM LONGUM[40 mg,500 mg] | Not identified |
| LACTOBACILLUS CASEI | LACTOBACILLUS CASEI[40 mg,500 mg] | Not identified |
| LACTOBACILLUS BULGARICUS | LACTOBACILLUS BULGARICUS[40 mg,500 mg] | Not identified |
| STREPTOCOCCUS THERMOPHILUS | STREPTOCOCCUS THERMOPHILUS[40 mg,500 mg] | Not identified |
| LACTOBACILLUS REUTERI | LACTOBACILLUS REUTERI[40 mg,500 mg] | Not identified |
| BIFIDOBACTERIUM BIFIDUM | BIFIDOBACTERIUM BIFIDUM[40 mg,500 mg] | Not identified |
| BIFIDOBACTERIUM LACTIS | BIFIDOBACTERIUM LACTIS[40 mg,500 mg] | Not identified |
| LACTOBACILLUS SALIVARIUS | LACTOBACILLUS SALIVARIUS[40 mg,500 mg] | Not identified |
| GALACTOOLIGOSACCHARIDES | GALACTOOLIGOSACCHARIDES[100 mg,500 mg] | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Original register data
View published fields and their variants
- Active ingredients
- LACTOBACILLUS ACIDOPHILUS[40 mg,500 mg],LACTOBACILLUS RHAMNOSUS[40 mg,500 mg],BIFIDOBACTERIUM LONGUM[40 mg,500 mg],LACTOBACILLUS CASEI[40 mg,500 mg],LACTOBACILLUS BULGARICUS[40 mg,500 mg],STREPTOCOCCUS THERMOPHILUS[40 mg,500 mg],LACTOBACILLUS REUTERI[40 mg,500 mg],BIFIDOBACTERIUM BIFIDUM[40 mg,500 mg],BIFIDOBACTERIUM LACTIS[40 mg,500 mg],LACTOBACILLUS SALIVARIUS[40 mg,500 mg],GALACTOOLIGOSACCHARIDES[100 mg,500 mg]
- Valid until
- 2027-04-08
- Registration date
- 2022-04-08
- Published description
- HEALTH SUPPLEMENT
- Licence holder
- GN NEUTRICEUTICALS SDN. BHD.
- Producer
- GN NEUTRICEUTICALS SDN. BHD.
- Published name
- GN BioNex Capsule
- Published reference
- 202203047070N
- Registration number
- MAL22046055N
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL22046055N
Ministère de la santé de Malaisie / NPRA, Pharmaceutical Products, CC BY 4.0
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.